Solventum Corporation (SOLV)

NYSE • Currently up 0.36 (+0.39%) in today's trading session

3 members of Congress have disclosed 3 trades in Solventum Corporation (SOLV) via STOCK Act filings. The most recent disclosure was a sale by J. French Hill on 31 December 2025. The most active traders have been J. French Hill (1), Julie Johnson (1), and Charles J. "Chuck" Fleischmann (1). Aggregate disclosed activity totals roughly $48.5K in sales (midpoint estimates from bracketed disclosure amounts).

Solventum Corporation is currently trading at $91.61, positioned at 99% of its 52-week range ($62.38 – $92.05).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Portfolio

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$91.61
24h Change
+0.36 (+0.39%)
52 Week Range
$62.38—$92.05
View on NASDAQ

Solventum Corporation Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for SOLV

Select to highlight on chart
3 transactions
Compliance: 100%
J. French Hill31 Dec 202523 Jan 2026SaleStock$15,001 - $50,000N/A
Julie Johnson15 Jan 202512 Feb 2025SaleStock$1,001 - $15,000N/A
Charles J. "Chuck" Fleischmann8 Jul 202416 Aug 2024SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$15.86B

Volume

1.03M

Beta

0.67

P/E Ratio

12.90

Fundamentals

EPS

$7.10

Div. Yield

—

Open

$90.79

Day Range

$90.35 — $92.05

Company Information

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NYSE · USD
Country
US
CEO
Bryan C. Hanson
IPO Date
2024-04-01
Website
www.solventum.com

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patien...

Earnings

Next Report

Q3 2026

5 Nov

EPS Est.

$1.35

Rev. Est.

$1.9B

Days Until

71

Recent Quarters

Q2 20265 Aug
EPS$2.55
Beat 34.2%
Q1 20265 May
EPS$1.48
Beat 9.6%
Q4 202526 Feb
EPS$1.57
Beat 4.7%
Q3 20256 Nov
EPS$1.50
Beat 4.9%
Q2 20257 Aug
EPS$1.69
Beat 16.6%
Q1 20258 May
EPS$1.34
Beat 10.7%
Q4 202427 Feb
EPS$1.41
Beat 7.6%
Q3 20247 Nov
EPS$1.64
Beat 18.0%
Q2 20248 Aug
EPS$1.56
Beat 3.3%
Q1 20249 May
EPS$2.08
Beat 18.9%
Q4 202311 Mar
EPS$2.31
Q2 202330 Sept
EPS$1.65
Q1 202330 Jun
EPS$1.86
Q4 202231 Mar
EPS$1.70
Q3 202231 Dec
EPS$1.78
Q2 202230 Sept
EPS$1.94
Q1 202230 Jun
EPS$2.03
Q4 202131 Mar
EPS$2.03

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about SOLV

Which members of Congress have traded SOLV?
3 members of Congress have disclosed 3 trades in Solventum Corporation (SOLV) under the STOCK Act. The most active traders are J. French Hill, Julie Johnson, and Charles J. "Chuck" Fleischmann.
When was SOLV most recently disclosed by Congress?
The most recent SOLV disclosure was a sale by J. French Hill on 31 December 2025.
What is the total disclosed congressional trading volume for SOLV?
Members of Congress have disclosed approximately $48.5K in SOLV sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in SOLV?
This SOLV page updates as soon as new STOCK Act disclosures are filed for Solventum Corporation. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.